These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25963773)

  • 21. The legal and ethical dimensions of direct-to-consumer advertising of prescription drugs: the case of Pfizer and Lipitor in the United States.
    Koku PS
    Health Mark Q; 2021; 38(1):23-34. PubMed ID: 34219606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 23. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor's prescription.
    Fogel J; Zhuk A
    Health Mark Q; 2019; 36(3):220-235. PubMed ID: 31267822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-to-consumer advertising of prescription medication in New Zealand.
    Every-Palmer S; Duggal R; Menkes DB
    N Z Med J; 2014 Aug; 127(1401):102-10. PubMed ID: 25225761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thinking outside the medicine cabinet: a comparative content analysis of direct-to-consumer advertisements for prescription drug treatments.
    McKeever R
    Health Mark Q; 2014; 31(4):353-69. PubMed ID: 25405635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws.
    Nathenson R; Richards MR
    Int J Health Econ Manag; 2018 Sep; 18(3):321-336. PubMed ID: 29380108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The federal regulation of prescription drug advertising and promotion.
    Kessler DA; Pines WL
    JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.
    DeFrank JT; Berkman ND; Kahwati L; Cullen K; Aikin KJ; Sullivan HW
    Health Commun; 2020 May; 35(6):739-746. PubMed ID: 30973021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct-to-Consumer Drug Advertisement and Prescribing Practices: Evidence Review and Practical Guidance for Clinicians.
    Franquiz MJ; McGuire AL
    J Gen Intern Med; 2021 May; 36(5):1390-1394. PubMed ID: 32930939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006-2009.
    Kim Y; Kornfield R; Shi Y; Vera L; Daubresse M; Alexander GC; Emery S
    Nicotine Tob Res; 2016 May; 18(5):1180-7. PubMed ID: 26385926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seeking clarity on help-seeking advertising.
    Amiry EJ; Gilbert J
    Br J Dermatol; 2019 Nov; 181(5):1063-1064. PubMed ID: 31021406
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies for patient empowerment through the promotion of medicines in Israel: regulatory framework for the pharmaceutical industry.
    Schwartzberg E; Barnett-Itzhaki Z; Grotto I; Marom E
    Isr J Health Policy Res; 2017 Sep; 6(1):50. PubMed ID: 28962636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimistic Bias and Consumer Prescription Drug Decisions: Influences of Direct to Consumer Advertising and Perceived Susceptibility.
    Ju I; Park T; Ohs J
    Health Commun; 2022 Nov; 37(13):1694-1703. PubMed ID: 33899598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct to consumer advertising in healthcare: history, benefits, and concerns.
    Adeoye S; Bozic KJ
    Clin Orthop Relat Res; 2007 Apr; 457():96-104. PubMed ID: 17310934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consumer's Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence.
    Ju I; Ohs JE; Park JS
    Health Commun; 2020 May; 35(6):696-706. PubMed ID: 30835557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy students' opinions of direct-to-consumer advertising: a pilot study at one university.
    Harrington AR; Desselle SP; Apgar DA; Hesselbacher E; Pié A; Quesnel A; Warholak TL
    Res Social Adm Pharm; 2013; 9(4):458-66. PubMed ID: 22999802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct marketing of pharmaceuticals to consumers.
    Lyles A
    Annu Rev Public Health; 2002; 23():73-91. PubMed ID: 11910055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Doran E
    Int J Health Policy Manag; 2016 Feb; 5(5):333-5. PubMed ID: 27239884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.